drugset / Trial / NCT02217267

Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain

NCT02217267 ↗

Phase 3 Completed 29 enrolled Mahidol University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study to evaluated Long term outcome after serial Lidocaine infusion when compared with placebo in peripheral neuropathic pain patients in acute stage (less than 6 months) at 3 months after first time of infusion

Timeline

Start
2014-08-01
Primary completion
2017-12-29
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 3 mg/kg Intravenous

Indications